{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiepxs6utxugeujhjm6hrahpjrvyxt4zulyyixxgy3psf535whcxpy",
    "uri": "at://did:plc:7nuyhqvd4a6xquezhjhvregv/app.bsky.feed.post/3mmlqi2mwk572"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiegzlbden2pojqpzqijz3ga7fbxdnfo2burbnoiqtztgr6f5f4sie"
    },
    "mimeType": "image/jpeg",
    "size": 473044
  },
  "path": "/2026/05/24/science/rfk-jr-antidepressants-ssri-psychiatry.html",
  "publishedAt": "2026-05-24T09:01:57.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "Psychiatry and Psychiatrists",
    "Antidepressants",
    "Mental Health and Disorders",
    "Depression (Mental)",
    "American Psychiatric Assn",
    "Health and Human Services Department",
    "Kennedy, Robert F Jr",
    "Food and Drug Administration"
  ],
  "textContent": "An annual psychiatric meeting was abuzz over Robert F. Kennedy Jr.’s call to rein in the use of depression medications. Some fear it will drive patients away from care.",
  "title": "RFK Jr.’s Push to Curb Antidepressants Has Shaken Psychiatry"
}